The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Methyl 6-(6-Guanidinohexanamido)-4-hydroxy-2-naphthoate ID: ALA5202463
PubChem CID: 168292593
Max Phase: Preclinical
Molecular Formula: C19H24N4O4
Molecular Weight: 372.43
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COC(=O)c1cc(O)c2cc(NC(=O)CCCCCNC(=N)N)ccc2c1
Standard InChI: InChI=1S/C19H24N4O4/c1-27-18(26)13-9-12-6-7-14(11-15(12)16(24)10-13)23-17(25)5-3-2-4-8-22-19(20)21/h6-7,9-11,24H,2-5,8H2,1H3,(H,23,25)(H4,20,21,22)
Standard InChI Key: BRWPQBVHUNXYSR-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 28 0 0 0 0 0 0 0 0999 V2000
-3.2119 -1.6493 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.2119 -0.8243 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9281 -0.4164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9281 0.4118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6425 0.8243 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.3570 0.4118 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-6.0714 0.8243 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6425 1.6493 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.2137 0.8240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5020 0.4122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5020 -0.4127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7844 -0.8267 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0729 -0.4101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0748 0.4106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7895 0.8230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3585 -0.8226 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.3558 -0.4101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3558 0.4148 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.0703 -0.8226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7848 -0.4101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4991 -0.8226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2136 -0.4101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9281 -0.8226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6425 -0.4101 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3569 -0.8226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0714 -0.4101 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3569 -1.6475 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 2 0
4 3 1 0
4 5 1 0
5 6 1 0
6 7 1 0
5 8 2 0
9 4 2 0
10 9 1 0
11 10 2 0
2 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
10 15 1 0
13 16 1 0
16 17 1 0
17 18 2 0
17 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
25 27 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 372.43Molecular Weight (Monoisotopic): 372.1798AlogP: 2.31#Rotatable Bonds: 8Polar Surface Area: 137.53Molecular Species: BASEHBA: 5HBD: 5#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 6#RO5 Violations (Lipinski): 1CX Acidic pKa: 8.68CX Basic pKa: 12.15CX LogP: 1.77CX LogD: 0.55Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.21Np Likeness Score: -0.25
References 1. Iannelli G, Milite C, Marechal N, Cura V, Bonnefond L, Troffer-Charlier N, Feoli A, Rescigno D, Wang Y, Cipriano A, Viviano M, Bedford MT, Cavarelli J, Castellano S, Sbardella G.. (2022) Turning Nonselective Inhibitors of Type I Protein Arginine Methyltransferases into Potent and Selective Inhibitors of Protein Arginine Methyltransferase 4 through a Deconstruction-Reconstruction and Fragment-Growing Approach., 65 (17.0): [PMID:35482954 ] [10.1021/acs.jmedchem.2c00252 ]